SystemsNarrow moat
Intuitive Surgical (ISRG) — moat facet
The robots, half of them now leased rather than sold, which turns a capital sale into a meter.
Systems are the da Vinci and Ion robots, and the line is smaller and more recurring than it looks. It had revenue of $2,473.7 million in 2025, from $1,966.0 million in 2024 and $1,679.7 million in 2023 1, a quarter of the company 2. Intuitive placed 1,721 da Vinci systems in 2025 against 1,526 a year earlier, 870 of them the new da Vinci 5 against 362 3.
Half of them were not sold. Of the 2025 placements, 872 were under operating leases, 51% of the total, against 659 and 48% in 2023; 496 of those leases were usage-based, where the hospital pays per procedure 4. Operating lease revenue, which is recorded in this line and counted as recurring, was $874.3 million in 2025, from $654.2 million and $500.5 million 5. A leased robot brings less revenue in the year it is placed and more over its life.
The line grew 26% in 2025 6, faster than instruments, because da Vinci 5 carries a higher price and because the lease base keeps growing. Part of the history since 2023 is a replacement cycle, with older systems traded in for the new platform.
The line's margin is not disclosed separately from instruments; product gross margin was 66.3% in 2025 7. It fell that year partly on higher costs associated with da Vinci 5 8, which is the cost of launching the new system.
The latest quarter continued the pattern. Systems revenue was $685.0 million in the June 2026 quarter against $574.7 million 9, reflecting a higher lease installed base, higher average selling prices and more placements 10. Intuitive placed 468 da Vinci systems, 246 of them da Vinci 5 11.
The outlook depends on hospital capital budgets, which the leases partly insulate. The figure to watch is placements under usage-based leases: rising while outright sales fall would mean hospitals are pushing the utilisation risk back onto Intuitive, which it can afford with no borrowings and about $8.6 billion of cash and investments 12, but which lowers the line's revenue in the year of placement.
Systems revenue rose to $685.0M in the June 2026 quarter from $574.7M, on leases, prices and placements.
Includes lease revenue; a fall with placements holding would mean more usage-based leases and less up-front revenue.
Source: Intuitive Surgical Form 10-Q, Q2 2026 ↗- ReportedIt had revenue of $2,473.7 million in 2025, from $1,966.0 million in 2024 and $1,679.7 million in 2023 , a quarter of the company .Intuitive Surgical Form 10-K FY2025 - revenue by line 2023-2025 (instruments and accessories, systems, service), recurring revenue and operating lease revenue, product and service gross margins, placements and leases, procedures and installed base, and the drivers of each — FY2023-FY2025 · publ. February 2026 · source ↗
- Moat Explorer calcIt had revenue of $2,473.7 million in 2025, from $1,966.0 million in 2024 and $1,679.7 million in 2023 , a quarter of the company .Moat Explorer calculation from Intuitive Surgical's Form 10-K FY2025 and Q2 2026 Form 10-Q: shares of revenue and growth rates — FY2023 to Q2 2026 · publ. 2026-09-23 · source ↗
- ReportedIntuitive placed 1,721 da Vinci systems in 2025 against 1,526 a year earlier, 870 of them the new da Vinci 5 against 362 .Intuitive Surgical Form 10-K FY2025 - revenue by line 2023-2025 (instruments and accessories, systems, service), recurring revenue and operating lease revenue, product and service gross margins, placements and leases, procedures and installed base, and the drivers of each — FY2023-FY2025 · publ. February 2026 · source ↗
- ReportedOf the 2025 placements, 872 were under operating leases, 51% of the total, against 659 and 48% in 2023; 496 of those leases were usage-based, where the hospital pays per procedure .Intuitive Surgical Form 10-K FY2025 - revenue by line 2023-2025 (instruments and accessories, systems, service), recurring revenue and operating lease revenue, product and service gross margins, placements and leases, procedures and installed base, and the drivers of each — FY2023-FY2025 · publ. February 2026 · source ↗
- ReportedOperating lease revenue, which is recorded in this line and counted as recurring, was $874.3 million in 2025, from $654.2 million and $500.5 million .Intuitive Surgical Form 10-K FY2025 - revenue by line 2023-2025 (instruments and accessories, systems, service), recurring revenue and operating lease revenue, product and service gross margins, placements and leases, procedures and installed base, and the drivers of each — FY2023-FY2025 · publ. February 2026 · source ↗
- ReportedThe line grew 26% in 2025 , faster than instruments, because da Vinci 5 carries a higher price and because the lease base keeps growing.Intuitive Surgical Form 10-K FY2025 - revenue by line 2023-2025 (instruments and accessories, systems, service), recurring revenue and operating lease revenue, product and service gross margins, placements and leases, procedures and installed base, and the drivers of each — FY2023-FY2025 · publ. February 2026 · source ↗
- ReportedThe line's margin is not disclosed separately from instruments; product gross margin was 66.3% in 2025 .Intuitive Surgical Form 10-K FY2025 - revenue by line 2023-2025 (instruments and accessories, systems, service), recurring revenue and operating lease revenue, product and service gross margins, placements and leases, procedures and installed base, and the drivers of each — FY2023-FY2025 · publ. February 2026 · source ↗
- ReportedIt fell that year partly on higher costs associated with da Vinci 5 , which is the cost of launching the new system.Intuitive Surgical Form 10-K FY2025 - revenue by line 2023-2025 (instruments and accessories, systems, service), recurring revenue and operating lease revenue, product and service gross margins, placements and leases, procedures and installed base, and the drivers of each — FY2023-FY2025 · publ. February 2026 · source ↗
- ReportedSystems revenue was $685.0 million in the June 2026 quarter against $574.7 million , reflecting a higher lease installed base, higher average selling prices and more placements .Intuitive Surgical Form 10-Q, quarter ended 30 June 2026 - revenue by line and region for Q2 and H1 2026, product and service gross margins, installed base — Q2 2026 · publ. July 2026 · source ↗
- ReportedSystems revenue was $685.0 million in the June 2026 quarter against $574.7 million , reflecting a higher lease installed base, higher average selling prices and more placements .Intuitive Surgical Q2 2026 results release (8-K exhibit 99.1) - procedure growth, drivers of instrument and systems revenue, placements, 2026 procedure growth guidance, cash and investments of $8.63 billion — Q2 2026 · publ. 21 July 2026 · source ↗
- ReportedIntuitive placed 468 da Vinci systems, 246 of them da Vinci 5 .Intuitive Surgical Q2 2026 results release (8-K exhibit 99.1) - procedure growth, drivers of instrument and systems revenue, placements, 2026 procedure growth guidance, cash and investments of $8.63 billion — Q2 2026 · publ. 21 July 2026 · source ↗
- ReportedThe figure to watch is placements under usage-based leases: rising while outright sales fall would mean hospitals are pushing the utilisation risk back onto Intuitive, which it can afford with no borrowings and about $8.6 billion of cash and investments , but which lowers the line's revenue in the year of placement.Intuitive Surgical Q2 2026 results release (8-K exhibit 99.1) - procedure growth, drivers of instrument and systems revenue, placements, 2026 procedure growth guidance, cash and investments of $8.63 billion — Q2 2026 · publ. 21 July 2026 · source ↗
- Intuitive Surgical Form 10-K, fiscal year ended December 31, 2025 (SEC EDGAR)
- Intuitive Surgical Form 10-Q, Q2 2026